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Abstract
Atherosclerosis is a vascular disorder consisting of thickening of arteries and lack of elas-
ticity. Result of atherosclerosis is that arteries become narrowed and hardened due to an 
excessive buildup of plaque around the artery wall. The disease disrupts the flow of blood 
around the body, posing serious cardiovascular complications. Arteries contain what is 
called an endothelium, a thin layer of cells that keeps the artery smooth and allows blood 
to flow easily. Endothelial damage starts the first step of atherosclerosis. After this, low-
density lipoprotein (LDL) cholesterol accumulates in the artery wall. Inflammatory pro-
cess starts after this accumulation, and macrophages reach the endothelium to clean up 
cholesterol. But some macrophages are stuck in the affected part of the artery wall in 
this process. Over time, this results in plaque being built up, consisting of cholesterol 
and macrophage white blood cells. The plaque clogs up the artery, disrupting the flow 
of blood. This potentially causes blood clots that can result in life-threatening conditions 
such as heart attack and other cardiovascular diseases. Atherosclerosis can be seen in all 
arteries in the body. Atherosclerosis is the most common cause of death in the western 
countries. Some risk factors are as follows: age, sex, familial predisposition, hyperlip-
idemia, hypertension, diabetes mellitus, smoking, obesity, insufficient physical activity, 
etc. Whatever the main reason or the risk factor is, once atherosclerosis is formed, several 
life-threatening cardiovascular disorders can be seen. So, it has to be revealed.
Keywords: atherosclerosis, coronary atherosclerosis, coronary artery disease, ischemic 
heart disease
1. Introduction
Atherosclerosis locution originates from the Greek-Latin word “atera” meaning “oat or milky 
mush.” It describes a vascular disorder consisting of thickening of arteries and lack of elastic-
ity. The general pathology refers to three situations:
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The predominant type is often seen with intimal fatty plaque formation including central 
lipid-rich core. We want to mention about this type of atherosclerosis.
The second morphologic type of atherosclerosis, Mönckeberg’s medial calcific sclerosis, is 
seen in the muscular arteries with a medial calcification. This form is not prominent as classic 
atherosclerosis and mostly seen after the age of 50. This can be seen radiologically and can be 
felt with palpation.
The third type is the disorders of the small arteries and arterioles, named arteriosclerosis. This 
is seen mostly with hypertensive and diabetic patients. This refers to stiffening or hardening 
of the artery walls.
The final result of atherosclerosis is that arteries become narrowed and hardened due to an 
excessive buildup of plaque around the artery wall. The disease disrupts the flow of blood 
around the body, posing serious cardiovascular complications.
Atherosclerosis can be seen in all arteries in the body. But we will instruct about the coronary 
atherosclerosis. Atherosclerosis is the most common cause of death in the western countries [1].
Arteries contain what is called an endothelium, a thin layer of cells that keeps the artery 
smooth and allows blood to flow easily. Endothelial damage starts the first step of athero-
sclerosis. After this LDL cholesterol accumulates in the artery wall. Inflammatory process 
starts after this accumulation, and macrophages reach the endothelium to clean up choles-
terol. But some macrophages stuck in the affected part of the artery wall in this process. 
Over time this results in plaque being built up, consisting of cholesterol and macrophage 
white blood cells.
The plaque clogs up the artery, disrupting the flow of blood. This potentially causes blood 
clots that can result in life-threatening conditions such as heart attack and other cardiovascular 
diseases.
Some risk factors are follows: age, sex, familial predisposition, hyperlipidemia, hypertension, 
diabetes mellitus, smoking, obesity, insufficient physical activity, etc. Whatever the main rea-
son or the risk factor is, once atherosclerosis is formed, several life-threatening cardiovascular 
disorders can be seen. So, it has to be revealed.
2. Background
The role of the circulation is to service the needs of the tissues. It includes transporting nutri-
ents to thecells of the body and waste products away from the cells of the body. And finally 
transporting hormones from one part of the body to another. Naturally, circulation maintains 
an appropriate environment in all the tissue fluids of the body for optimal survival and func-
tion of the cells.
Systemic circulation, pulmonary circulation, peripheral circulation, etc. have some details to 
maintain the blood flow. The arteries are the large conductive vessels that transport blood 
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under high pressure to the tissues. The arterioles are the last small branches of the arterial 
system. And, the capillaries are where the exchange of fluid, electrolytes, nutrients, hormones, 
and other substances occurs. And, of course veins, venules, collect blood from the capillaries. 
Our main subject is atherosclerosis of arterial vessels.
We have to learn the normal state before discussing the pathological status. The normal artery 
wall is consisting of intima, media, and adventitia. Lumen is lined by a monolayer of endo-
thelial cells that overlies smooth muscle cells. The inner layer of smooth muscle cells, known 
as the intima, is circumscribed by the internal elastic lamina. The media layer is between 
the internal elastic lamina and external elastic lamina. The media is another layer of smooth 
muscle cells. Outside the external elastic lamina is an adventitia part that is rarely populated 
by cells and microvessels of the vasa vasorum.
Atherosclerosis is a progressive disease of medium- and large-sized arteries characterized 
by focal intimal lesions called atheromas or atherosclerotic plaques that protrude into vessel 
lumen and eventually leading to various complications [2]. There are several diseases led by 
atherosclerosis: coronary artery disease, peripheral artery disease, and carotid artery disease. 
These are real threats for mortality and morbidity in the developed countries.
3. Pathophysiology
Atherosclerosis is a chronic, inflammatory, fibroproliferative disease of medium- and large-
sized arteries [3]. There are different stages to form the atherosclerotic plaque. The initiation 
phase is the beginning and the progression of the plaque and the final complication stage.
Chronic or recurrent endothelial damage is the cornerstone of the “response to damage” 
hypothesis. Hyperlipidemia, hypertension, smoking, immunoreactions, hemodynamic fac-
tors, toxins, and viruses can cause this chronic endothelial damage. Hemodynamic deformities 
such as endothelial shear stress, turbulent flow, or unfavorable effects of hypercholesterol-
emia have a role in the initiation phase. Due to endothelial damage and turbulent flow, endo-
thelial permeability, cell regeneration, and receptor-mediated LDL endocytosis and leukocyte 
adhesion to endothelium increase.
Hyperlipidemia has an important role in the atherogenesis [4]. Chronic hyperlipidemia 
especially hypercholesterolemia can start the endothelial damage. After all, lipoproteins 
accumulate in these damaged endothelial sites. The cellular response after endothelial dam-
age continues with increased permeability, leukocyte adhesion, monocyte migration, and 
increased adhesion. This is no longer the initiation phase after this stage; progression has 
started.
Some cellular events take an important part in this phase. Smooth muscles migrate from the 
media layer to intima and macrophages activated. Monocytes turn to macrophages. Activated 
macrophages, and smooth muscle cells absorb lipids. Modified lipid molecules due to the 
oxidative mechanisms of modified LDL arise. Oxide LDL makes some additive affects, in 
order; (a) with the help of altered receptors LDL absorbed easily by macrophages (b) they 
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are chemotactic to circulating monocytes (c) they enhance adhesion of monocytes (d) they 
prevent the mobility of macrophages because of this macrophages remain their position and 
hold on to there (e) they are cytotoxic to endothelium and smooth muscle cells (f) they are 
immunogenic.
The endothelial damage is like as peeling of the endothelium, because of this damage platelets 
hold on to the endothelium. Smooth muscle cells derived from media layer migrate to here 
and starts to duplicate and some of them absorb lipids inside and turns to the foam like cells. 
And this is shown as fatty streaks.
After this stage macrophages take a leading role in atherosclerosis. Macrophages secrete 
interleukin-1 (IL-1) and tumor necrosis factor (TNF), and they are increasing leukocyte adhe-
sion. Again, monocyte chemoattractant protein-1 (MCP-1) produced by macrophages collects 
leukocytes in the plaque. They have a role to oxidate the LDL. And finally, they secrete stimu-
lators to affecting the smooth muscle cell growth [5].
Fatty streaks are seen in the childhood phase. This lesion starts as a small 1-mm-diameter 
intimal color change. With the organization of atherosclerosis, this lesion varies 1–3 mm in 
diameter and 1–2 cm long. Some of them are raised and some of them not.
Atheromatous plaque is the definitive lesion, and it is rich in lipids, but more often it is a lipid 
and fibrotic lesion. Sometimes, this solid and fibrotic characterized plaque can be rich with 
cells. Plaques’ diameter can reach to a few cm. Its color changes according to the amount of 
the lipid. It is changed to a round shape and has an irregular shape.
Atheromatous plaques can be seen in the different parts of the body. The prevelence of 
involvement is in order; Abdominal aorta, coronary arteries, popliteal arteries, descending 
thoracic aorta, internal carotid arteries and the circle of Willis.
Finally, microscopically atherosclerotic plaque has got the main components. These are lip-
ids, vascular smooth cells, monocytes/macrophages, rarely lymphocytes, connective tissue 
matrix, and fibrils (Figure 1).
But more importantly, atherosclerotic plaque changes to four different types. These are com-
plicated plaques:
a. Calcification of the arteries. They can be seen as a consecutive island, and some of them 
can be in the whole artery.
b. Ulceration of the surface of the atherosclerotic plaque. This can cause embolization.
c. Platelet aggregation can occur on the ulcerated plaque. This can lead to total occlusion of 
the artery. The most devastating effect of atherosclerosis such as heart attack and stroke is 
caused by the superimposed thrombosis.
d. Atherosclerotic aneurysm can occur due to atherosclerosis.
e. This ulceration can break endothelial integrity, and this can causes rupture of the plaque 
and can cause bleeding.
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4. Epidemiology and etiology
Due to the asymptomatic phase of atherosclerosis, it is impossible to say the frequency of ath-
erosclerosis, because the process of atherosclerosis starts with fatty streak in the first decade 
of lifetime. More advanced lesions begin to develop when individuals are in their second and 
third decade. Complicated coronary atherosclerosis causes coronary artery disease (CAD) after 
all. CAD remains the most common pathology with which cardiologists and cardiac surgeons 
are facing. It is the most common cause of death in Turkey in 2013 [6]; 38.8% of the deaths were 
due to the ischemic cardiovascular disease. Ischemic heart disease is the most common cause of 
death in the world as reported by the World Health Organization (WHO) in 2012 [7].
Inactivation of genes coding for monocyte chemotactic protein-1 (MCP-1), its receptor on 
monocyte/macrophages (CCR2), and macrophage colony-stimulating factor has a profound 
impact on the development of atherosclerosis in otherwise identical mice that have been 
shown in the experimental studies [8]. The etiology of atherosclerosis is unknown, but in 
the development process of atherosclerosis, the pathophysiology is important to explain the 
nature. There are some important risk factors in this process. We have to classify risk factors 
in two. These are modifiable and non-modifiable risk factors.
Figure 1. The stages of the progression of atherosclerosis.
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5. Risk factors
5.1. Non-modifiable risk factors
a. Increased age.
b. Male gender: lack of atheroprotective properties of estrogen which raises HDL and lowers 
LDL.
c. Hereditary factors: history of coronary artery disease (CAD) among first-degree relatives 
at a young age (before 55 for males and before 65 for females). New markers of the cardio-
vascular risk factors:
d. Increased lipoprotein(a) level.
e. Increased homocysteine level: high levels may promote oxidative stress, vascular inflam-
mation, and platelet adhesiveness. And, this process leads to atherosclerosis. A meta-anal-
ysis that collected a large number of prospective studies showed a significant association 
between the serum level of homocysteine and the incidence of cardiovascular disease [9]. 
Not just with it, increased blood homocysteine levels are shown in patients with acute 
myocardial infarction [10].
f. C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), and other markers of inflam-
mation: activate complement and contribute to a sustained inflammatory state. CRP is a 
biomarker of tissue damage and inflammation. It is an acute-phase reactant and increases 
in the inflammatory process. But nowadays, it has been used in the diagnosis of the car-
diovascular diseases such as CAD. Sara et al. have showed that hs-CRP is associated with 
coronary endothelial dysfunction in the asymptomatic coronary artery disease [11].
5.2. Modifiable risk factors
a. Dyslipidemia: increased LDL and decreased high-density lipoprotein (HDL).
b. Tobacco smoking: enhances oxidative modification of LDL, contributes to endothelial dys-
function via oxidant stress, and increases expression of leukocyte adhesion molecules.
c. Hypertension: increases permeability of the vessel wall to lipoproteins and promotes re-
tention of LDL in the vessel intima by accentuating production of LDL-binding proteogly-
cans by smooth muscle cells.
d. Diabetes mellitus: enhances glycation of LDL and is associated with endothelial 
dysfunction.
e. Obesity and lack of physical activity: can cause dyslipidemia, hypertension, and insulin 
resistance.
f. Stressful lifestyle: better known as Type A personality.
5.3. Atheroprotective factors
a. Exercise
b. High-density lipoprotein (HDL) and its major apolipoprotein (ApoA1)
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Coronary atherosclerosis is an important site of atherosclerosis. There are various types of 
results due to coronary atherosclerosis. Especially, the size of the plaque and the type of 
the complicated plaque are important for this. Whatever the beginning of the atheromatous 
plaque, the result can be a fatal heart attack. In developed countries atherosclerosis causes 
more than half of total mortality. Coronary artery disease (CAD) is responsible for a major 
proportion of these deaths [12].
6. Signs and symptoms
Onset of the atherosclerotic plaque and speed of the growth and complications, there are 
several signs and symptoms. Atherosclerosis can be seen in every artery, but for the coronary 
atherosclerosis, the result of the disease is coronary artery disease, and the symptoms and the 
signs are due to this. Because of the impaired blood flow, there is a sort of symptoms. Some 
of them are in the side of the chest, and some of them are systemic because of the impaired 
circulation.
• Chest pain
• Shortness of breath
• Weakness, tiredness, reduced exertional capacity
• Dizziness, palpitations
• Leg swelling
• Weight gain
• Diaphoresis
• Tachycardia: common in persons with acute coronary syndrome (ACS) and acute myocar-
dial infarction (AMI)
• High or low blood pressure
• S
4
 gallop: a common early finding
• S
3
 gallop: an indication of reduced left ventricular function
• Heart murmurs
• Tachypnea
• Xanthelasmas
• Livedo reticularis
• Syncope
• Leg edema
• Rales
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Coronary atherosclerosis causes coronary artery disease. Complicated atherosclerotic plaque 
disrupts the blood flow in the coronary circulation. Impaired blood flow causes a corrupted 
supply and demand of the oxygen and the metabolites in the heart. This results in a decrease in 
coronary arterial blood flow and a decrease in oxygen supply. There are several symptoms such 
as chest pain (angina pectoris), dyspnea, syncope, and sometimes pulmonary edema. Increased 
demand of blood supply and oxygen starts the angina pectoris. Because of the decreased blood 
flow in coronary artery, sufficient blood cannot be supplied in the increased effort capacity. 
The spectrum of presentation includes symptoms and signs consistent with the following 
conditions:
• Asymptomatic state (subclinical phase)
• Stable angina pectoris
• Unstable angina (i.e., acute coronary syndrome)
• Acute myocardial infarction (AMI)
• Chronic ischemic cardiomyopathy
• Congestive heart failure
• Sudden cardiac arrest
7. Diagnosis and treatment
Atherosclerosis can be seen in all the arterial sites in the whole body as mentioned before. So, 
the physical examination can give us very important findings. A well-taken medical history 
and physical examination can be helpful for the diagnosis. Suspicious findings can lead us to 
make a decision for the advanced examination.
Medical history is the cornerstone of diagnosis. A positive history of typical chest pain, short-
ness of breath, impaired physical capacity, and the other signs and symptoms are very useful 
to diagnosis.
Atherosclerosis can cause both coronary artery and peripheral artery diseases. Concomitant 
coronary and peripheral artery disease prevalence is varied 28–94% in published reports [13]. 
So, on the calcified peripheral artery, palpation or lack of pulse in the peripheral arteries or 
signs of the peripheral artery disease are important parts of the physical examination.
What are the parts of the advanced examination?
Electrocardiography (ECG): impaired blood flow in acute events such as acute myocardial 
infarction and acute coronary syndromes are the changes we can see in the ECG.
Echocardiography (ECO): atherosclerotic calcification or plaque and thickness of aortic wall can 
be seen in ECO. Ventricular low ejection fraction and impaired contraction of ventricular seg-
ments can suspect us for coronary atherosclerosis.
Stress echocardiography: this echocardiography can be performed either by exercise method or 
pharmacological drugs that increase cardiac contractility and rate.
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Exercise echocardiography: images are taken before and after the treadmill or stationary bike 
effort test. If exercise echocardiography cannot be performed due to peripheral artery dis-
ease, musculoskeletal disorders, etc., drug-stimulated (dobutamine, adenosine, dipyridam-
ole) stress echocardiography can be performed. These drugs increase the cardiac contractility 
and rhythm. Doses of the drugs increases step by step, and images are taken gradually.
The purpose is to assess the exercise tolerance of the heart. If there is a myocardial perfusion 
defect due to coronary artery disease, stress echocardiography can give information about 
this. The severity of the coronary artery disease can be assessed with this test. Before and 
after revascularization either PCI or CABG cardiac risk can be evaluated. It can be performed 
for cardiac risk analyses for noncardiac surgeries. Exercise echocardiography can be used for 
risk stratification in asymptomatic patients with severe aortic stenosis too [14]. Yao et al. have 
showed in their clinical study; as the result of the exercise tests, monophasic/normal wall 
motion was associated with a benign prognosis, but abnormal wall motion responses were 
associated with a worse prognosis [15].
Myocardial perfusion scintigraphy: can show us the ischemic parts of the heart due to the occlu-
sive effect of coronary atherosclerosis leading to coronary artery disease.
Computed tomography (CT): conventional thoracoabdominal CT scan can show atherosclerotic 
calcification and plaques in the aortic or arterial wall. But coronary CT scan can show us the 
presence of coronary atherosclerosis, the degree of the coronary artery disease, and the occlu-
sive lesions.
Intravenous ultrasound (IVUS): can be useful for the controversial lesions. This is an invasive 
technique that localizes plaques and quantifies plaque seriousness. Virtual histology-intra-
vascular ultrasound (VH-IVUS) can identify plaque components. Optical coherence tomog-
raphy (OCT), also known as optical frequency domain imaging (OFDI), identifies intimal 
hyperplasia and also detects and quantifies the key features of vulnerable plaque [16].
Coronary angiography: is the gold standard for diagnosis of coronary atherosclerosis and coro-
nary artery disease. Moving image of each coronary artery and the atherosclerotic lesions can 
be seen. It is the most specific and sensitive test for the diagnosis of coronary artery disease.
Coronary angiography can come out to such results. This can be a follow-up with medical 
therapy, a percutaneous coronary intervention can be necessary, or a coronary artery bypass 
grafting (CABG) is essential to be performed to the patient. All of the interventions are selected 
due to the percentage of the affected coronary artery lesion, the lesion type, lesion location, 
the number of the affected coronary artery, and of course the general condition of the patient.
Treatment: There are several treatment modalities. These include lifestyle changes, risk factor 
modification, and medical therapies. But we want to mention about the clinically important 
occlusive coronary artery diseases’ invasive treatment.
Percutaneous coronary intervention (PCI): it is also known as coronary angioplasty, and this 
is a nonsurgical technique to treat obstructive coronary artery disease. It can be a choice in 
stable angina pectoris, in acute myocardial infarction, or in multivessel coronary artery dis-
ease. The procedure is performed in angiography catheter laboratory. An x-ray fluoroscopy 
and opaque fluid are necessary for the procedure. Entry ways for the procedure are femoral 
arteries and radial arteries for the individual cases.
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Some urgent cases such as acute myocardial infarction PCI can be performed emergent. 
Primary PCI is called in this situation. But also PCI is used for elective coronary artery disease 
usually. The procedure starts with a local anesthesia from the arterial puncture side; this can 
be even femoral or radial artery. Hydrophilic and micro-catheters and guidewires are used 
to reach coronary arteries. These radiopaque wires are seen easily on fluoroscopy. A balloon 
angioplasty can be performed to the occlusive lesion. Coronary stents can be implanted to the 
occluded lesion. Coronary stents vary from bare metal stents to drug eluding stent. These drug 
eluding stents vary to the first, second, and third generation. Nowadays, fourth-generation 
bioresorbable stents are mentioned in some clinical trials [17]. Whatever the kind of the stents, 
the main purpose is to improve blood flow of the myocardium tissue.
Coronary artery bypass grafting (CABG): so, is this the only technique that we can improve 
blood supply of the myocardium? Is there any other way of myocardial revascularization? 
The answer is yes. It is coronary artery bypass grafting (CABG). This is an open cardiac surgi-
cal procedure. This means that it is more invasive than PCI. But in some cases, PCI cannot be 
the concluding treatment for the coronary artery disease. Lesion type, region of the lesion, 
collateral and main side branches extending from the lesion, severity of the lesion, and the 
number of the lesions is important for the physician to make the choice.
Before explaining CABG, we have to mention the indications and guidelines (Table 1 and 2).
7.1. Guidelines for coronary artery bypass graft surgery
7.1.1. Asymptomatic CAD
7.1.1.1. Class I
1. LMC stenosis.[18, 20]
2. LMCE disease.
3 Three-vessel disease.
Revascularization CABG DES
No risk DM LVD No risk DM LVD
One-vessel disease
Proximal LAD
N N N Y Y Y
Y Y Y N N N
Two-vessel disease without LAD
Two-vessel disease with LAD
N N N Y Y Y
Y Y Y Y Y Y
Two-vessel disease + proximal LAD
Three-vessel disease
Y Y Y N N N
Y Y Y C C C
Three-vessel + proximal LAD
LMC ± other lesions
Y Y Y N N N
Y Y Y N N N
CABG, coronary artery bypass grafting; DES, drug-eluting stent; DM, diabetes mellitus; LAD, left anterior descending 
artery; LMC, left main coronary artery disease; LVD, left ventricular dysfunction. *Y, yes; N, no; C, controversial.
Table 1. The reality of myocardial revascularization strategies in patients with isolated coronary artery disease [18].
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7.1.1.2. Class IIa
(1) Proximal LAD (one- or two-vessel disease)
7.1.1.3. Class IIb
(1) One- or two-vessel disease not involving proximal LAD (if a large territory at risk on non-
invasive studies or LVEF <50%, class IIa and IIb become class I indications)
7.1.2. Stable angina
7.1.2.1. Class I
1. LMC stenosis.
2. LMCE disease.
3. Three-vessel disease.
4. Two-vessel disease with proximal LAD stenosis and LVEF <50% or demonstrable ischemia.
5. One- or two-vessel disease without proximal LAD stenosis but with a large territory at risk 
and high-risk criteria on noninvasive testing.
6. Disabling angina refractory to medical therapy.
7.1.2.2. Class IIa
1. Proximal LAD stenosis with one-vessel disease.
2. One- or two-vessel disease without proximal LAD stenosis, but with a moderate territory 
at risk and demonstrable ischemia.
Recommendation CABG PCI
Class Level Class Level
One or two-vessel disease without LAD IIb C I C
One-vessel disease with proximal LAD I A I A
Two-vessel disease with proximal LAD I B I C
LMC with SYNTAX score < 22 I B I B
LMC with SYNTAX score 23–32 I B IIb B
LMC with SYNTAX score > 32 I B III B
Three-vessel disease SYNTAX score > 22 I A I B
Three-vessel disease SYNTAX score 23–32 I A III B
Three-vessel disease SYNTAX score > 32 I A III B
Recommendation for the type of revascularization (CABG or PCI) in patients with stable CAD with suitable coronary 
anatomy for both procedures [19].
Table 2. 2014 ESC/EACTS Guidelines on myocardial revascularization guidelines.
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7.1.3. Unstable angina/non-ST-segment elevation MI (non-STEMI)
7.1.3.1. Class I
1. LMC stenosis.
2. LMCE disease.
3. Ongoing ischemia not responsive to maximal nonsurgical therapy.
7.1.3.2. Class IIa
Proximal LAD stenosis with one- or two-vessel disease.
7.1.3.3. Class IIb
One- or two-vessel disease without proximal LAD stenosis when PCI not possible (becomes 
class I if high-risk criteria on noninvasive testing).
7.1.4. ST-segment elevation (Q wave) MI
7.1.4.1. Class I
1. Failed PCI with persistent pain or shock and anatomically feasible.
2. Persistent or recurrent ischemia refractory to medical treatment with acceptable anatomy, 
which has a significant territory at risk and not a candidate for PCI.
3. Requires surgical repair of post-infarct VSD or MR.
4. Cardiogenic shock in patients <75 years of age who have ST elevation, LBBB, or a posterior 
MI within 18 hours onset.
5. Life-threatening ventricular arrhythmias in the presence of ≥50% LMC stenosis or three-
vessel disease.
7.1.4.2. Class IIa
1. Primary reperfusion in patients who have failed fibrinolytics or PCI and are in the early 
stages (6–12 h) of an evolving STEMI.
2. Mortality with CABG is elevated in the first 3–7 days after STEMI/NSTEMI. After 7 days, 
criteria for CABG in previous section are applied.
7.1.5. Poor LV function
7.1.5.1. Class I
1. LMC.
2. LMCE.
3. Proximal LAD stenosis and two- to three-vessel disease.
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7.1.5.2. Class IIa
Significant viable territory and noncontractile myocardium.
7.1.6. Life-threatening ventricular arrhythmias
7.1.6.1. Class I
1. LMC.
2. Three-vessel disease.
7.1.6.2. Class IIa
1. Bypassable one- or two-vessel disease.
2. Proximal LAD disease and one- or two-vessel disease. These become class I indications if 
arrhythmia is resuscitated cardiac death or sustained ventricular tachycardia.
7.1.7. Failed PCI
7.1.7.1. Class I
1. Ongoing ischemia with significant territory at risk.
2. Shock.
7.1.7.2. Class IIa
1. Foreign body in critical position.
2. Shock with coagulopathy and no previous sternotomy.
7.1.7.3. Class IIb
Shock with coagulopathy and previous sternotomy.
7.1.8. Previous CABG
7.1.8.1. Class I
1. Disabling angina refractory to medical therapy.
2. Nonpatent previous bypass grafts, but with class I indications for native CAD.
7.1.8.2. Class IIa
1. Large territory at risk.
2. Vein grafts supplying LAD or large territory are “/> 50% stenosed.
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Class I: Conditions for which there is evidence and/or general agreement that a given proce-
dure or treatment is useful and effective.
Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion 
about the usefulness or efficacy of a procedure.
Class IIa: Weight of evidence/opinion is in favor of usefulness/efficacy.
Class IIb: Usefulness/efficacy is less well established by evidence/opinion.
Class III: Conditions for which there is evidence and/or general agreement that the procedure/
treatment is not useful/effective and in some cases may be harmful.
ACC, American College of Cardiology; AHA, American Heart Association; CABG, coronary 
artery bypass grafting; CAD, coronary artery disease; LAD, left anterior descending artery; 
LBBB, left bundle branch block, LMC, left main coronary artery; LMCE, left main coronary 
equivalent; LVEF, left ventricular ejection fraction; MI, myocardial infarction; MR, mitral 
regurgitation; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous translumi-
nal coronary angioplasty; STEMI, ST elevation myocardial infarction; VSD, ventricular septal 
defect [20].
There are several grafts that are used in CABG. Arterial grafts such as left internal and right 
internal mammary artery (LIMA and RIMA), especially LIMA has got the longest patency 
rate (10-year patency is 95%). Radial artery can be used, but it is a muscular artery and has got 
a predisposition to vasospasm. Vena saphena magna is the most used venous graft.
This procedure can be performed with cardiopulmonary bypass (CPB) machine (on-pump), 
without CPB (off-pump CABG-OPCAB), or beating heart procedures. In the last decade, min-
imally invasive techniques are rising to individual cases. MIDCAB (minimally invasive direct 
coronary artery bypass) can be performed without full median sternotomy. This can serve 
minimal surgical trauma and avoid wound complication.
TECAB: this is a robotically assisted total endoscopic coronary artery bypass procedure. This 
is a complex procedure; surgeon has to steep a learning curve. This procedure can perform 
both on-pump and off-pump CABG.
Awake coronary artery bypass (ACAB) procedure: This avoids side effects of general anesthe-
sia. This includes a minimal invasive procedure without intubation and mechanical ventila-
tory support. A somatosensory and motor block is made via the T1–T8 level of vertebra. This 
preserves diaphragmatic ventilation.
Early outcomes after CABG continue to improve, and the early cumulative mortality rate is 
below 2% and lower than 1% in lower-risk patients. The most common reasons for death are 
heart failure (65%), neurologic events (7.5%), hemorrhage (7%), respiratory failure (5.5%), and 
dysrhythmia (5.5%).
The survival rate after isolated CABG is higher than 98% for the first month and 97% for first 
year, 92% for 5 years, 80% for 10 years, 65% for 15 years, and 51% for 20 years. Usage of LIMA 
is a predictive parameter for late survival.
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8. Prevention
Prevention of the coronary atherosclerosis has to be lifelong. Individuals need to be careful for 
risk factors. Adopting a healthy lifestyle. What is inside of this healthy lifestyle?
Healthy eating habit for the heart: eating habits are very important in the process of devel-
oping atherosclerosis. Healthy diet consists of low amounts of white bread, unsaturated fat 
products, fast foods, salt, and sugar. It also includes eating dairy products, fruits, vegetables, 
whole grain, seafood, poultry without skin, lean meats, low-fat milk, or fat-free milk.
After the start of healthy diet for the heart, weight control can be achieved, because over-
weight and obese people have high risk for coronary atherosclerosis.
Physical activity: stressful and sedentary lifestyles are the risk factors for coronary atheroscle-
rosis. So, a programmed physical activity can improve the fitness level and the health of the 
individuals.
Figure 2. Ten year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol 
and smoking status.
Focus on Coronary Atherosclerosis
http://dx.doi.org/10.5772/intechopen.77301
17
8.1. Stopping tobacco smoking
We have to mention about risk scores and charts. Risk scores can give us several information 
about the cardiac risk of our body. This can lead the person to change avoidable habits.
Framingham Risk Score: age, sex, cigarette smoking, cholesterol level, high-density lipopro-
tein (HDL) cholesterol level, systolic blood pressure, and usage of antihypertensive drugs. 
Some clinics include diabetes mellitus (DM), low-density lipoprotein (LDL) cholesterol, and 
diastolic blood pressure to modify this risk score.
Another risk score system is SCORE risk charts. This includes SCORE—European High Risk 
Chart and SCORE—European Low Risk Chart. This score system is based on gender, age, 
total cholesterol, systolic blood pressure, and cigarette smoking (Figures 2 and 3).
9. Conclusion
Coronary atherosclerosis and coronary artery disease (CAD) are the most frequent causes of 
hospitalization in western countries. It is an important mortality and morbidity cause. The 
Figure 3. Ten year risk of fatal CVD in low risk regions of Europe by gender, age, systolic blood pressure, total cholesterol 
and smoking status.
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onset of the first lesions begins in the first decade of the life period and proceeds with the life-
time. Risk factors are important and decisive for the progression of the atheromatous plague. 
A healthy and modified life is the key to prevent from the disease.
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